Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Egerer

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Deutsches Arzteblatt International|July 7, 2009
The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigensKarl Egerer, Eugen Feist, Gerd-Rüdiger Burmester
Current Opinion in Rheumatology|April 23, 2004
Rheumatoid factor revisitedThomas Dörner, Karl Egerer, Eugen Feist, et al.
RMD Open|August 30, 2017
Automated evaluation of ANA under real-life conditionsClemens Dario Loock, Karl Egerer, Eugen Feist, et al.
Clinical Chemistry|September 23, 2006
Circulating proteasomes are functional and have a subtype pattern distinct from 20S proteasomes in major blood cellsAnnette Zoeger, Michael Blau, Karl Egerer, et al.
Arthritis and Rheumatism|May 23, 2012
Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et alDirk Roggenbuck, Karl Egerer, Eugen Feist, et al.
Electrophoresis|December 20, 2011
Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS--application to rheumatoid arthritisElena Frisch, Matthias Kaup, Karl Egerer, et al.
The Journal of Rheumatology|May 5, 2010
Effects of early rituximab retreatment in rheumatoid arthritis patients with an inadequate response after the first cycle: retrospective arthritis cohort studyHans Bastian, Silke Zinke, Karl Egerer, et al.
Clinical and Experimental Rheumatology|April 24, 2010
Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV)Christopher Schneeweis, Michael Rafalowicz, Eugen Feist, et al.
Arthritis and Rheumatism|August 12, 2003
sE-selectin for stratifying outcome in rheumatoid arthritisKarl Egerer, Julia Hertzer, Eugen Feist, et al.
Autoimmunity Reviews|September 26, 2012
Antiphospholipid antibody profiling: time for a new technical approach?Dirk Roggenbuck, Karl Egerer, Philipp von Landenberg, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Deutsches Arzteblatt International|July 7, 2009
The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigensKarl Egerer, Eugen Feist, Gerd-Rüdiger Burmester
Current Opinion in Rheumatology|April 23, 2004
Rheumatoid factor revisitedThomas Dörner, Karl Egerer, Eugen Feist, et al.
RMD Open|August 30, 2017
Automated evaluation of ANA under real-life conditionsClemens Dario Loock, Karl Egerer, Eugen Feist, et al.
Clinical Chemistry|September 23, 2006
Circulating proteasomes are functional and have a subtype pattern distinct from 20S proteasomes in major blood cellsAnnette Zoeger, Michael Blau, Karl Egerer, et al.
Arthritis and Rheumatism|May 23, 2012
Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et alDirk Roggenbuck, Karl Egerer, Eugen Feist, et al.
Electrophoresis|December 20, 2011
Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS--application to rheumatoid arthritisElena Frisch, Matthias Kaup, Karl Egerer, et al.
The Journal of Rheumatology|May 5, 2010
Effects of early rituximab retreatment in rheumatoid arthritis patients with an inadequate response after the first cycle: retrospective arthritis cohort studyHans Bastian, Silke Zinke, Karl Egerer, et al.
Clinical and Experimental Rheumatology|April 24, 2010
Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV)Christopher Schneeweis, Michael Rafalowicz, Eugen Feist, et al.
Arthritis and Rheumatism|August 12, 2003
sE-selectin for stratifying outcome in rheumatoid arthritisKarl Egerer, Julia Hertzer, Eugen Feist, et al.
Autoimmunity Reviews|September 26, 2012
Antiphospholipid antibody profiling: time for a new technical approach?Dirk Roggenbuck, Karl Egerer, Philipp von Landenberg, et al.
Pageof 4